SCHEMBL27508117

SCHEMBL27508117

OC1c2ccccc2C(O)c2sc(-c3ccccc3F)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MPL P40238 1/20 0.34
▸ RAB9A P51151 5/20 0.34
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ MAPT P10636 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ S1PR1 P21453 1/20 0.33
▸ DCUN1D1 Q96GG9 1/20 0.33
▸ F2RL3 Q96RI0 1/20 0.32
▸ GUSB P08236 1/20 0.32
▸ APEX1 P27695 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27506102 0.81 ALOX5 (0.46) ALDH1A1KDM4ERAB9ANPC1MAPT
SCHEMBL27531535 0.80 ALDH1A1 (0.42) ALDH1A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL27491448 0.77 TRPM8 (0.47) KDM4ESMN1; SMN2
SCHEMBL27492138 0.76 KDM4E (0.47) ALDH1A1KDM4ERAB9ANPC1MEN1
SCHEMBL27491451 0.75 KDM4E (0.50) ALDH1A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL27505330 0.75 KDM4E (0.49) ALDH1A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL27507729 0.74 PDPK1 (0.40) RAB9A
SCHEMBL27505716 0.72 ALOX5 (0.36) RAB9AGAA
SCHEMBL27490767 0.72 PDPK1 (0.36) ALDH1A1KDM4ESMN1; SMN2MAPTGAA
SCHEMBL27505331 0.72 MAOA (0.34) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1204323-A Use of tricyclic 1,4-dihydro-1,4-dioxo-1 H-naphthalene derivatives, resulting novel compounds and therapeutical use thereof INNOTHERA LAB SA (FR) 1999-01-06 — — CN disclosed
Send feedback